Gabriel Yariv
Presidente presso CNBX PHARMACEUTICALS INC.
Profilo
Gabriel Yariv was the founder of Instituto Simutec, founded in 2010, where he held the title of Chief Executive Officer from 2010 to 2017.
He was also the founder of The Yariv Foundation For Leadership Ltd., founded in 2006, where he held the title of Chief Executive Officer from 2006 to 2009.
Mr. Yariv's current job(s) include being the Chairman & Chief Operating Officer at CNBX Pharmaceuticals, Inc. since 2019, a Director at TaGeza Biopharmaceuticals Ltd., and a Member at Friends of The Israel Museum Society.
Mr. Yariv's education history includes undergraduate studies at Boston University.
Posizioni attive di Gabriel Yariv
| Società | Posizione | Inizio |
|---|---|---|
| CNBX PHARMACEUTICALS INC. | Presidente | 05/09/2021 |
| Friends of The Israel Museum Society | Corporate Officer/Principal | - |
TaGeza Biopharmaceuticals Ltd.
 TaGeza Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TaGeza Biopharmaceuticals Ltd. develops immunotherapy and cancer-targeted pharmaceuticals. The private company is based in Tel Aviv Jaffa, Israel. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Gabriel Yariv
| Società | Posizione | Fine |
|---|---|---|
| Instituto Simutec | Fondatore | 01/01/2017 |
| The Yariv Foundation For Leadership Ltd. | Amministratore Delegato | 01/01/2009 |
Formazione di Gabriel Yariv
| Boston University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CNBX PHARMACEUTICALS INC. | Health Technology |
| Aziende private | 4 |
|---|---|
| Instituto Simutec | |
| Friends of The Israel Museum Society | |
| The Yariv Foundation For Leadership Ltd. | |
TaGeza Biopharmaceuticals Ltd.
TaGeza Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TaGeza Biopharmaceuticals Ltd. develops immunotherapy and cancer-targeted pharmaceuticals. The private company is based in Tel Aviv Jaffa, Israel. | Health Technology |
- Borsa valori
- Insiders
- Gabriel Yariv
